Furthermore, it was discovered that by concurrently blocking the MAPK/c-Myc/cyclin D1 and STAT3/SOX2 pathways, a combination of DHT and MAPK pathway inhibitors could accelerate the death of melanoma cells. The gene discussed is MYC; the disease is melanoma.